The immunogenicity of biopharmaceuticals.
Schellekens
Huub
H
Utrecht University, Rotterdam, The Netherlands. h.schellekens@gdl.uu.nl
D000917:Antibody Formation / Q000276:immunology; D001688:Biological Products / Q000009:adverse effects / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000276:immunology; D011994:Recombinant Proteins / Q000009:adverse effects / Q000276:immunology*; D012010:Red-Cell Aplasia, Pure / Q000276:immunology
D001688:Biological Products; D011994:Recombinant Proteins